{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:29:58Z","timestamp":1787772598819,"version":"build-2784847793"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a complicated, inflammatory disease that causes demyelination of the central nervous system (CNS), resulting in a variety of neurological abnormalities. Over the past several decades, different animal models have been used to replicate the clinical symptoms and neuropathology of MS. The experimental model of experimental autoimmune\/allergic encephalomyelitis (EAE) and viral and toxin-induced model was widely used to investigate the clinical implications of MS. Discoidin domain receptor 1 (DDR1) signaling in oligodendrocytes (OL) brings a new dimension to our understanding of MS pathophysiology. DDR1 is effectively involved in the OL during neurodevelopment and remyelination. It has been linked to many cellular processes, including migration, invasion, proliferation, differentiation, and adhesion. However, the exact functional involvement of DDR1 in developing OL and myelinogenesis in the CNS remains undefined. In this review, we critically evaluate the current literature on DDR1 signaling in OL and its proliferation, migration, differentiation, and myelination mechanism in OL in association with the progression of MS. It increases our knowledge of DDR1 in OL as a novel target molecule for oligodendrocyte-associated diseases in the CNS, including MS.<\/jats:p>","DOI":"10.4103\/ejpi.ejpi-d-24-00043","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:30:30Z","timestamp":1724434230000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Functional Role of DDR1 in Oligodendrocyte Signaling Mechanism in Association with Myelination and Remyelination Process in the Central Nerve System"],"prefix":"10.4103","volume":"67","author":[{"given":"Mariadoss Arokia Vijaya","family":"Anand","sequence":"first","affiliation":[{"name":"Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Shivamadhaiah","family":"Manjula","sequence":"additional","affiliation":[{"name":"Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Zen","family":"Wang","sequence":"additional","affiliation":[{"name":"Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Regeneration Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Physiology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"R1-20240906","first-page":"1","article-title":"Multiple sclerosis:Pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J"},{"key":"R3-20240906","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/appi.ajp.159.11.1862","article-title":"Depressive symptoms and severity of illness in multiple sclerosis:Epidemiologic study of a large community sample","volume":"159","author":"Chwastiak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R4-20240906","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R5-20240906","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"key":"R6-20240906","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1002\/wsbm.1583","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech Dis"},{"key":"R7-20240906","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/01.WNL.0000129828.03714.90","article-title":"Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS","volume":"63","author":"Huijbregts","year":"2004","journal-title":"Neurology"},{"key":"R8-20240906","first-page":"91","article-title":"Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis","author":"Dulamea","year":"2017","journal-title":"In:Multiple Sclerosis:Bench to Bedside:Global Perspectives on a Silent Killer"},{"key":"R9-20240906","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis:Pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann Neurol"},{"key":"R10-20240906","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies:A new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R11-20240906","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"R12-20240906","doi-asserted-by":"crossref","first-page":"i3518","DOI":"10.1136\/bmj.i3518","article-title":"Disease modifying therapies for relapsing multiple sclerosis","volume":"354","author":"Wingerchuk","year":"2016","journal-title":"BMJ"},{"key":"R13-20240906","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152709788680670","article-title":"Treatment of multiple sclerosis","volume":"8","author":"Anlar","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R14-20240906","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","article-title":"The window of therapeutic opportunity in multiple sclerosis:Evidence from monoclonal antibody therapy","volume":"253","author":"Coles","year":"2006","journal-title":"J Neurol"},{"key":"R15-20240906","doi-asserted-by":"crossref","first-page":"17562864211007687","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"R16-20240906","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis:Identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"key":"R17-20240906","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.05.010","article-title":"B cell follicle-like structures in multiple sclerosis-with focus on the role of B cell activating factor","volume":"273","author":"Haugen","year":"2014","journal-title":"J Neuroimmunol"},{"key":"R18-20240906","doi-asserted-by":"crossref","first-page":"1028653","DOI":"10.3389\/fncel.2022.1028653","article-title":"Glial cells and neurologic autoimmune disorders","volume":"16","author":"Li","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"R19-20240906","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/jnnp.2008.171132","article-title":"Multiple sclerosis:The bare essentials","volume":"9","author":"Coles","year":"2009","journal-title":"Pract Neuro"},{"key":"R20-20240906","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/msj.20249","article-title":"Immunologic aspects of multiple sclerosis","volume":"78","author":"Boppana","year":"2011","journal-title":"Mt Sinai J Med"},{"key":"R21-20240906","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis:Experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"R22-20240906","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis:Focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J Neurosci Res"},{"key":"R23-20240906","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1167\/iovs.10-6425","article-title":"Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods","volume":"52","author":"Enriquez-Algeciras","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20240906","doi-asserted-by":"crossref","first-page":"106230","DOI":"10.1016\/j.nbd.2023.106230","article-title":"An overall view of the most common experimental models for multiple sclerosis","volume":"184","author":"Dedoni","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R25-20240906","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med"},{"key":"R26-20240906","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1172\/JCI29834","article-title":"A mighty mouse:Building a better model of multiple sclerosis","volume":"116","author":"Ransohoff","year":"2006","journal-title":"J Clin Invest"},{"key":"R27-20240906","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1177\/1352458511414755","article-title":"Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis","volume":"17","author":"Sheridan","year":"2011","journal-title":"Mult Scler"},{"key":"R28-20240906","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R29-20240906","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R30-20240906","first-page":"217","article-title":"Induktion von paralyse und r\u00fcckenmarksentz\u00fcndung durch immunisierung von kaninchen mit menschlichem r\u00fcckenmarksgewebe","volume":"42","author":"Koritschoner","year":"1925","journal-title":"Z Immunit\u00e4tsf Exp Ther"},{"key":"R31-20240906","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/15525","article-title":"Ahumanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor","volume":"23","author":"Madsen","year":"1999","journal-title":"Nat Genet"},{"key":"R32-20240906","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/187152712801661220","article-title":"Viruses and multiple sclerosis","volume":"11","author":"Virtanen","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R33-20240906","doi-asserted-by":"crossref","first-page":"114579","DOI":"10.1016\/j.expneurol.2023.114579","article-title":"Altered T cell development in an animal model of multiple sclerosis","volume":"371","author":"Jiang","year":"2024","journal-title":"Exp Neurol"},{"key":"R34-20240906","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpain.2023.07.022","article-title":"Anovel sensory wave (P25) in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis murine model","volume":"25","author":"Shulman","year":"2024","journal-title":"J Pain"},{"key":"R35-20240906","doi-asserted-by":"crossref","first-page":"111303","DOI":"10.1016\/j.intimp.2023.111303","article-title":"Astragalus polysaccharides promote neural stem cells-derived oligodendrogenesis through attenuating CD8(+) T cell infiltration in experimental autoimmune encephalomyelitis","volume":"126","author":"Zhao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R36-20240906","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1871527320666211207101113","article-title":"Lactose and casein cause changes on biomarkers of oxidative damage and dysbiosis in an experimental model of multiple sclerosis","volume":"21","author":"Escribano","year":"2022","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R37-20240906","doi-asserted-by":"crossref","first-page":"148648","DOI":"10.1016\/j.brainres.2023.148648","article-title":"Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis","volume":"1822","author":"Gilbert","year":"2024","journal-title":"Brain Res"},{"key":"R38-20240906","doi-asserted-by":"crossref","first-page":"1237078","DOI":"10.3389\/fmmed.2023.1237078","article-title":"Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model","volume":"3","author":"Zerimech","year":"2023","journal-title":"Front Mol Med"},{"key":"R39-20240906","doi-asserted-by":"crossref","first-page":"137497","DOI":"10.1016\/j.neulet.2023.137497","article-title":"Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expression","volume":"815","author":"Kalinin","year":"2023","journal-title":"Neurosci Lett"},{"key":"R40-20240906","doi-asserted-by":"crossref","first-page":"103094","DOI":"10.1016\/j.jaut.2023.103094","article-title":"Harnessing autoimmunity with dominant self-peptide:Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues","volume":"140","author":"Lin","year":"2023","journal-title":"J Autoimmun"},{"key":"R41-20240906","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bpa.12916","article-title":"Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG (35-55)-induced EAE through ERK and Akt signalling","volume":"31","author":"Kamali","year":"2021","journal-title":"Brain Pathol"},{"key":"R42-20240906","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-019-1415-6","article-title":"Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE","volume":"16","author":"Yue","year":"2019","journal-title":"J Neuroinflammation"},{"key":"R43-20240906","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ana.410440317","article-title":"Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients","volume":"44","author":"Mayne","year":"1998","journal-title":"Ann Neurol"},{"key":"R44-20240906","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jnnp.64.4.539","article-title":"Altered antibody pattern to epstein-barr virus but not to other herpesviruses in multiple sclerosis:A population based case-control study from Western Norway","volume":"64","author":"Myhr","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-20240906","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12031-013-0026-4","article-title":"Cuprizone-induced demyelination as a tool to study remyelination and axonal protection","volume":"51","author":"Zendedel","year":"2013","journal-title":"J Mol Neurosci"},{"key":"R46-20240906","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte death and myelin loss in the cuprizone model:An updated overview of the intrinsic and extrinsic causes of cuprizone demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol Neurodegener"},{"key":"R47-20240906","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination:A primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"key":"R48-20240906","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-019-1586-1","article-title":"Dynamic response of microglia\/macrophage polarization following demyelination in mice","volume":"16","author":"Chu","year":"2019","journal-title":"J Neuroinflammation"},{"key":"R49-20240906","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","article-title":"The relevance of animal models in multiple sclerosis research","volume":"18","author":"Denic","year":"2011","journal-title":"Pathophysiology"},{"key":"R50-20240906","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2018.10.038","article-title":"Direct targeting of the mouse optic nerve for therapeutic delivery","volume":"313","author":"Mesentier-Louro","year":"2019","journal-title":"J Neurosci Methods"},{"key":"R51-20240906","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jnc.15142","article-title":"Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice","volume":"156","author":"Yamazaki","year":"2021","journal-title":"J Neurochem"},{"key":"R52-20240906","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-020-02258-z","article-title":"Selective vulnerability of inhibitory networks in multiple sclerosis","volume":"141","author":"Zoupi","year":"2021","journal-title":"Acta Neuropathol"},{"key":"R53-20240906","doi-asserted-by":"crossref","first-page":"114755","DOI":"10.1016\/j.bbr.2023.114755","article-title":"Role of MAPK and PI3K-Akt signaling pathways in cuprizone-induced demyelination and cognitive impairment in mice","volume":"458","author":"Xu","year":"2024","journal-title":"Behav Brain Res"},{"key":"R54-20240906","doi-asserted-by":"crossref","first-page":"578286","DOI":"10.1016\/j.jneuroim.2024.578286","article-title":"Effects of treadmill training on myelin proteomic markers and cerebellum morphology in a rat model of cuprizone-induced toxic demyelination","volume":"387","author":"Lotfi","year":"2024","journal-title":"J Neuroimmunol"},{"key":"R55-20240906","doi-asserted-by":"crossref","first-page":"105645","DOI":"10.1016\/j.neuint.2023.105645","article-title":"Interleukin-33 has the protective effect on oligodendrocytes against impairment induced by cuprizone intoxication","volume":"172","author":"Huang","year":"2024","journal-title":"Neurochem Int"},{"key":"R56-20240906","doi-asserted-by":"crossref","first-page":"116128","DOI":"10.1016\/j.biopha.2024.116128","article-title":"Exosome-specific loading Sox10 for the treatment of cuprizone-induced demyelinating model","volume":"171","author":"He","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R57-20240906","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41536-023-00345-9","article-title":"Myeloid cell-associated aromatic amino acid metabolism facilitates CNS myelin regeneration","volume":"9","author":"Hu","year":"2024","journal-title":"NPJ Regen Med"},{"key":"R58-20240906","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jnc.16037","article-title":"Transforming growth factor-?1 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model","volume":"168","author":"Xie","year":"2024","journal-title":"J Neurochem"},{"key":"R59-20240906","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2119\/molmed.2011.00457","article-title":"Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice","volume":"18","author":"Hagemeyer","year":"2012","journal-title":"Mol Med"},{"key":"R60-20240906","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.neurobiolaging.2005.06.008","article-title":"Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination","volume":"27","author":"Zhao","year":"2006","journal-title":"Neurobiol Aging"},{"key":"R61-20240906","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2008.02.161","article-title":"Anew EAE model of brain demyelination induced by intracerebroventricular pertussis toxin","volume":"370","author":"Zhao","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R62-20240906","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2007.11.005","article-title":"Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL\/6 mice","volume":"210","author":"Hoffmann","year":"2008","journal-title":"Exp Neurol"},{"key":"R63-20240906","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1750-3639.2008.00230.x","article-title":"SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination","volume":"19","author":"Taylor","year":"2009","journal-title":"Brain Pathol"},{"key":"R64-20240906","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12974-020-02020-y","article-title":"Deficiency of microglial Hv1 channel is associated with activation of autophagic pathway and ROS production in LPC-induced demyelination mouse model","volume":"17","author":"Chen","year":"2020","journal-title":"J Neuroinflammation"},{"key":"R65-20240906","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2016.08.048","article-title":"Acute axonal damage in three different murine models of multiple sclerosis:A comparative approach","volume":"1650","author":"H\u00f6flich","year":"2016","journal-title":"Brain Res"},{"key":"R66-20240906","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1007\/s12035-015-9420-y","article-title":"Lesion expansion in experimental demyelination animal models and multiple sclerosis lesions","volume":"53","author":"Gro\u00dfe-Veldmann","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R67-20240906","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2009.07.010","article-title":"Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis","volume":"220","author":"Kerstetter","year":"2009","journal-title":"Exp Neurol"},{"key":"R68-20240906","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol"},{"key":"R69-20240906","doi-asserted-by":"crossref","first-page":"22594","DOI":"10.1038\/s41598-021-01963-3","article-title":"Cuprizone feed formulation influences the extent of demyelinating disease pathology","volume":"11","author":"Toomey","year":"2021","journal-title":"Sci Rep"},{"key":"R70-20240906","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","article-title":"Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination\/remyelination","volume":"61","author":"Mason","year":"2000","journal-title":"J Neurosci Res"},{"key":"R71-20240906","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.004","article-title":"Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination","volume":"453","author":"Lindner","year":"2009","journal-title":"Neurosci Lett"},{"key":"R72-20240906","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol Scand Suppl"},{"key":"R73-20240906","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"R74-20240906","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/glia.23706","article-title":"The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury","volume":"68","author":"Duncan","year":"2020","journal-title":"Glia"},{"key":"R75-20240906","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1044-7431(03)00210-0","article-title":"NG2-expressing glial progenitor cells:An abundant and widespread population of cycling cells in the adult rat CNS","volume":"24","author":"Dawson","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"R76-20240906","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.01.006","article-title":"Oligodendrocyte dynamics in the healthy adult CNS:Evidence for myelin remodeling","volume":"77","author":"Young","year":"2013","journal-title":"Neuron"},{"key":"R77-20240906","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"R78-20240906","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","article-title":"Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures","volume":"22","author":"Marton","year":"2019","journal-title":"Nat Neurosci"},{"key":"R79-20240906","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1074\/jbc.RA119.011163","article-title":"The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors","volume":"295","author":"Zhang","year":"2020","journal-title":"J Biol Chem"},{"key":"R80-20240906","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/123.1.105","article-title":"Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis","volume":"123","author":"Wolswijk","year":"2000","journal-title":"Brain"},{"key":"R82-20240906","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Oligodendrocyte generation dynamics in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"R83-20240906","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ajpath.2013.04.016","article-title":"Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis","volume":"183","author":"Cui","year":"2013","journal-title":"Am J Pathol"},{"key":"R84-20240906","doi-asserted-by":"crossref","first-page":"1181817","DOI":"10.3389\/fdmed.2023.1181817","article-title":"Discoidin domain receptors;an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism","volume":"4","author":"Franceschi","year":"2023","journal-title":"Front Dent Med"},{"key":"R85-20240906","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.3390\/ijms22126535","article-title":"The journey of DDR1 and DDR2 kinase inhibitors as rising stars in the fight against cancer","volume":"22","author":"Elkamhawy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R86-20240906","first-page":"386","article-title":"DDR1 and DDR2 in skin","volume":"12","author":"Cario","year":"2018","journal-title":"Cell Adh Migr"},{"key":"R87-20240906","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2010.03.099","article-title":"Expression of the tyrosine kinase discoidin domain receptor 1 (DDR1) in human central nervous system myelin","volume":"1336","author":"Roig","year":"2010","journal-title":"Brain Res"},{"key":"R88-20240906","doi-asserted-by":"crossref","first-page":"118483","DOI":"10.1016\/j.bbamcr.2019.04.010","article-title":"Expression of DDR1 in the CNS and in myelinating oligodendrocytes","volume":"1866","author":"Vilella","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R89-20240906","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-800180-6.00002-5","article-title":"Discoidin domain receptor functions in physiological and pathological conditions","volume":"310","author":"Leitinger","year":"2014","journal-title":"Int Rev Cell Mol Biol"},{"key":"R90-20240906","doi-asserted-by":"crossref","first-page":"118474","DOI":"10.1016\/j.bbamcr.2019.04.004","article-title":"DDR1 role in fibrosis and its pharmacological targeting","volume":"1866","author":"Moll","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R91-20240906","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1091\/mbc.e05-11-1068","article-title":"A discoidin domain receptor 1\/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1\/3 activation and cell migration","volume":"17","author":"Wang","year":"2006","journal-title":"Mol Biol Cell"},{"key":"R92-20240906","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12964-023-01252-8","article-title":"Extracellular matrix-induced signaling pathways in mesenchymal stem\/stromal cells","volume":"21","author":"Novoseletskaya","year":"2023","journal-title":"Cell Commun Signal"},{"key":"R93-20240906","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1002\/brb3.2309","article-title":"Coexpression of the discoidin domain receptor 1 gene with oligodendrocyte-related and schizophrenia risk genes in the developing and adult human brain","volume":"11","author":"Muntan\u00e9","year":"2021","journal-title":"Brain Behav"},{"key":"R94-20240906","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1101\/gad.821600","article-title":"Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons","volume":"14","author":"Bhatt","year":"2000","journal-title":"Genes Dev"},{"key":"R95-20240906","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpsychires.2022.12.020","article-title":"Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls","volume":"158","author":"Gas","year":"2023","journal-title":"J Psychiatr Res"},{"key":"R96-20240906","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/jre.12986","article-title":"Effects of DDR1 on migration and adhesion of periodontal ligament cells and the underlying mechanism","volume":"57","author":"Wang","year":"2022","journal-title":"J Periodontal Res"},{"key":"R97-20240906","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2217\/epi-2021-0006","article-title":"DDR1 methylation is associated with bipolar disorder and the isoform expression and methylation of myelin genes","volume":"13","author":"Garcia-Ruiz","year":"2021","journal-title":"Epigenomics"},{"key":"R98-20240906","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpsychires.2018.12.021","article-title":"Discoidin domain receptor 1 gene variants are associated with decreased white matter fractional anisotropy and decreased processing speed in schizophrenia","volume":"110","author":"Gas","year":"2019","journal-title":"J Psychiatr Res"},{"key":"R99-20240906","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2011.07580.x","article-title":"The discoidin domain receptor 1 gene has a functional A2RE sequence","volume":"120","author":"Roig","year":"2012","journal-title":"J Neurochem"},{"key":"R100-20240906","doi-asserted-by":"crossref","first-page":"10318","DOI":"10.3390\/ijms241210318","article-title":"Evidence that DDR1 promotes oligodendrocyte differentiation during development and myelin repair after injury","volume":"24","author":"Mei","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R101-20240906","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12031-008-9151-x","article-title":"Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro","volume":"38","author":"Franco-Pons","year":"2009","journal-title":"J Mol Neurosci"},{"key":"R102-20240906","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroscience.2006.02.033","article-title":"Expression of discoidin domain receptor 1 during mouse brain development follows the progress of myelination","volume":"140","author":"Franco-Pons","year":"2006","journal-title":"Neuroscience"},{"key":"R103-20240906","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/ijms24021742","article-title":"DDR1 and its ligand, collagen IV, are involved in in vitro oligodendrocyte maturation","volume":"24","author":"Silva","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R104-20240906","doi-asserted-by":"crossref","first-page":"e10480","DOI":"10.1371\/journal.pone.0010480","article-title":"MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells","volume":"5","author":"Letzen","year":"2010","journal-title":"PLoS One"},{"key":"R105-20240906","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jpsychires.2012.02.018","article-title":"Increased expression of the spliced DDR1c isoform in brain tissues from schizophrenia patients","volume":"46","author":"Roig","year":"2012","journal-title":"J Psychiatr Res"},{"key":"R106-20240906","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-015-3285-7","article-title":"Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer","volume":"150","author":"Toy","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R107-20240906","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.18632\/oncotarget.6524","article-title":"IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K\/AKT pathway","volume":"7","author":"Mat\u00e0","year":"2016","journal-title":"Oncotarget"},{"key":"R108-20240906","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.1158\/0008-5472.CAN-06-1215","article-title":"Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation","volume":"66","author":"Das","year":"2006","journal-title":"Cancer Res"},{"key":"R109-20240906","first-page":"305","article-title":"Anovel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer","volume":"12","author":"Belfiore","year":"2018","journal-title":"Cell Adh Migr"},{"key":"R110-20240906","doi-asserted-by":"crossref","first-page":"17672","DOI":"10.1074\/jbc.M111.236612","article-title":"DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation","volume":"286","author":"Kim","year":"2011","journal-title":"J Biol Chem"},{"key":"R111-20240906","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.celrep.2019.02.096","article-title":"Interaction of discoidin domain receptor 1 with a 14-3-3-beclin-1-Akt1 complex modulates glioblastoma therapy sensitivity","volume":"26","author":"Vehlow","year":"2019","journal-title":"Cell Rep"},{"key":"R112-20240906","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S1431927616000787","article-title":"Collagen fibril ultrastructure in mice lacking discoidin domain receptor 1","volume":"22","author":"Tonniges","year":"2016","journal-title":"Microsc Microanal"},{"key":"R113-20240906","doi-asserted-by":"crossref","first-page":"dev200636","DOI":"10.1242\/dev.200636","article-title":"Discoidin domain receptor regulates ensheathment, survival and caliber of peripheral axons","volume":"149","author":"Corty","year":"2022","journal-title":"Development"},{"key":"R114-20240906","first-page":"2731","article-title":"NEP:A novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia","volume":"8","author":"Zerlin","year":"1993","journal-title":"Oncogene"},{"key":"R115-20240906","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1242\/jcs.046219","article-title":"The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA","volume":"122","author":"Huang","year":"2009","journal-title":"J Cell Sci"},{"key":"R116-20240906","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-5793(02)02360-8","article-title":"Ligand-induced shedding of discoidin domain receptor 1","volume":"514","author":"Vogel","year":"2002","journal-title":"FEBS Lett"}],"container-title":["Journal of Physiological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-24-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:05:20Z","timestamp":1787771120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-24-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ejpi.ejpi-d-24-00043","relation":{},"ISSN":["2950-6344","2950-6352"],"issn-type":[{"value":"2950-6344","type":"print"},{"value":"2950-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}